IntuitionLabs
Florence Healthcare GxP validation services for clinical research sponsors, CROs, and sites

Florence Healthcare Validation — 21 CFR Part 11, GAMP 5 & ICH E6(R3)

Risk-based GxP validation of Florence eBinders, eHub, and eConsent for sponsors, CROs, AMCs, and sites — IQ/OQ/PQ, periodic review, continuous-release regression testing, and inspection support.

Florence Validation at a Glance

Florence runs in a regulated clinical context. We deliver a complete GxP validation package that satisfies 21 CFR Part 11, EU Annex 11, ICH E6(R3), and GAMP 5 — sized to risk, not to checklist.

Foundation
Risk-Based Validation
FMEA-based risk assessment drives test depth. High-risk workflows (signatures, audit trail, eHub) get full scripted testing; lower-risk configurations get exploratory testing per FDA CSA principles.
CSV approach
Operations
Continuous-Release Testing
Frozen regression suites run on every Florence platform release. Risk-based regression with automation keeps the validated state intact across the continuous-release SaaS cadence.
Plan validation
Inspections
Inspection Readiness
Inspection-ready binder exports, audit trail access, training records, and rehearsed inspector hosting protocols. Continuous self-audit against FDA BIMO and EMA GCP inspection expectations.
Discuss inspection support

21 CFR Part 11 & EU Annex 11 Controls

Florence provides Part 11-compliant electronic signatures with printed name, date/time, and meaning of signature; immutable audit trails on every regulated action; access controls; and SOC 2 / ISO 27001 hosting. We deliver the validation artifacts — URS, configuration specs, FMEA-based risk assessment, IQ/OQ/PQ, traceability matrix, validation summary report — that turn out-of-the-box capability into inspection-ready operations under 21 CFR Part 11 and EU Annex 11.

21 CFR Part 11 and EU Annex 11 validation controls applied to Florence Healthcare

GAMP 5 Category 4 as the Operating Model

We validate Florence as a GAMP 5 Category 4 configured SaaS product. Validation focuses on configuration verification, integration testing, and intended-use testing — not on re-testing platform code that Florence has already verified. The GAMP 5 Second Edition guidance on iterative delivery and continuous-release SaaS shapes our test design so revalidation is proportionate to risk.

GAMP 5 Category 4 validation model applied to Florence Healthcare SaaS deployment

Aligned to ICH E6(R3) GCP

ICH E6(R3) calls for risk-based quality management, fit-for-purpose technology, and proportionate validation. Florence supports the controlled essential document handling, risk-based monitoring, and ALCOA+ data integrity that E6(R3) expects. Our validation pattern matches that risk-based posture — heavier where patient safety and data integrity risk is highest, lighter where risk is contained.

ICH E6(R3) Good Clinical Practice alignment for Florence Healthcare validation

Validation Deliverables We Produce

A complete Florence validation package mapped to GAMP 5 and the FDA CSA paradigm. Every artifact ties back to a documented risk assessment and a requirement in the URS.

Validation Plan

High-level validation strategy aligned to GAMP 5 Category 4, with scope, roles, deliverables, schedule, and exit criteria. Filed and approved before any test execution begins.

See the framework

User Requirements Specification

URS traceable to 21 CFR Part 11, EU Annex 11, ICH E6(R3), the TMF Reference Model, and your organizational SOPs. Each requirement carries a risk rating that drives downstream test depth.

Plan validation

FMEA Risk Assessment

Failure mode and effects analysis covering signatures, audit trail, role-based access, eHub document flow, integrations, and disaster recovery. Drives test prioritization per FDA CSA principles.

CSV methodology

IQ/OQ/PQ Protocols

Installation qualification (tenant provisioning), operational qualification (intended-use scripted testing), and performance qualification (real-world workflows under load) — executed with reviewed, signed evidence.

Talk to an expert

Traceability Matrix

Requirements-to-test traceability mapping every URS line to a test case and result. Foundational for inspection response and for surgical regression testing on platform releases.

See the format

Periodic Review SOP

Standard operating procedure for the structured annual (or more frequent) re-confirmation that the validated state holds. Includes change-log review, regression results, deviations, training, and supplier qualification refresh.

Managed validation

Why Risk-Based Validation Works for Florence

Florence is a continuous-release SaaS platform. Traditional waterfall CSV — heavy scripted testing on every release — does not fit that operating model and produces a backlog that compounds across the customer base. We replace it with a risk-based GAMP 5 / FDA CSA pattern that delivers fit-for-purpose assurance without the validation tax.

Right-Sized to Risk

Patient-safety and data-integrity workflows get full scripted testing. Lower-risk configurations get exploratory and unscripted testing per FDA CSA.

Automated Where it Pays

Frozen regression suites cover the highest-risk regulated workflows and run on every platform release with automated reporting into the validation record.

Continuous Periodic Review

Periodic review reuses the same evidence the validation produced. The same team that validated Florence carries the system knowledge forward.

Regulatory Frameworks We Cover

📜

21 CFR Part 11

Electronic records and electronic signatures for FDA-regulated trials. Full Part 11 controls including meaning of signature, audit trail integrity, and access control validation.

🇪🇺

EU Annex 11

European GMP/GCP computerised systems requirements including supplier qualification, validation lifecycle, periodic review, and incident management.

🌐

ICH E6(R3) GCP

Risk-based Good Clinical Practice including risk-based quality management, fit-for-purpose technology, and proportionate validation across the trial lifecycle.

⚙️

GAMP 5 Second Edition

ISPE GAMP 5 risk-based validation including iterative and agile delivery patterns suitable for continuous-release SaaS like Florence.

✅

FDA CSA

Computer Software Assurance — risk-based, fit-for-purpose assurance over exhaustive scripted testing. Reduces validation burden without compromising compliance.

🛡️

ALCOA+ Data Integrity

MHRA and FDA data integrity expectations — Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, Available — embedded in every Florence workflow.

Getting Started With Florence Validation

Every Florence validation engagement starts with a discovery workshop to confirm scope — which Florence modules are in use (eBinders, eHub, eConsent, eSource), which integrations are GxP-impacting, which regulatory frameworks apply (FDA, EMA, PMDA, MHRA), and what the inspection history and risk appetite look like. From there we build a fit-for-purpose validation plan that delivers compliance without over-engineering.

Our validation team holds active practice in computer system validation, 21 CFR Part 11 software development, and risk-based GAMP 5 across the life sciences software landscape. We have hosted and supported sponsor, CRO, and site inspections by FDA BIMO, EMA, MHRA, and PMDA with Florence as the system of record.

Validation Engagement Models

  • Validation Project — Full IQ/OQ/PQ delivery for a new Florence tenant including integrations
  • Retrospective Validation — Bringing an existing Florence tenant into a documented validated state
  • Periodic Review — Annual structured re-confirmation that the validated state holds
  • Inspection Support — Pre-inspection rehearsal, on-call support during inspections, response drafting

Frequently Asked Questions

Florence provides the technical controls required to support 21 CFR Part 11 and EU Annex 11: Part 11-compliant electronic signatures with printed name, date/time, and meaning of signature; immutable audit trails on every document and binder action; password and session policy enforcement; and SOC 2 Type II / ISO 27001 certified hosting. Full regulatory compliance is a shared responsibility — the customer is accountable for validated configuration, periodic reviews, change control SOPs, and supplier qualification of Florence itself. IntuitionLabs delivers the validation artifacts, periodic review framework, and supplier audit support that bridge out-of-the-box capability to inspection-ready operations.
Florence is treated as a GAMP 5 Category 4 configured product. That means validation focuses on configuration verification, integration testing, and intended-use testing — not on re-testing platform code that Florence has already verified. The GAMP 5 Second Edition guidance on iterative and agile delivery and continuous-release SaaS keeps the validation footprint proportionate to risk. We use risk-based regression test suites and DevOps automation so seasonal platform releases are routine events rather than fire drills.
A complete Florence validation package typically includes: a validation plan; a user requirements specification (URS) traceable to applicable regulations and SOPs; a configuration specification capturing every workspace, role, binder template, and signature workflow; an FMEA-based risk assessment that drives test depth; installation, operational, and performance qualification protocols and reports (IQ/OQ/PQ); a requirements-to-test traceability matrix; a validation summary report; and a periodic review SOP and schedule. For integrated deployments we add interface specifications and integration test protocols for every connected system — Medidata, Veeva Vault, Calyx, Suvoda, IRB systems, and identity providers.
ICH E6(R3) emphasizes risk-based quality management, fit-for-purpose technology, and proportionate validation. Florence aligns with E6(R3) in several ways: it provides the controlled essential document handling expected of investigator site files; it supports risk-based monitoring through controlled monitor access and tamper-evident source documents; it captures every regulated action in an immutable audit trail; and it provides the data integrity controls (ALCOA+) called for by both ICH E6(R3) and the MHRA GxP data integrity guidance.
Florence delivers continuous releases via its multi-tenant SaaS model — heavy re-validation cycles do not fit that operating model. We replace big-bang revalidation with risk-based regression testing on every release. A frozen regression test suite covering the highest-risk regulated workflows (signature, audit trail, role-based access, eHub document flow) runs on every Florence release, results are reviewed by the validation lead, and a release impact assessment is filed before promoting the release to production tenants. Supplier-side release notes from Florence are reviewed for in-scope changes that warrant additional testing.
Supplier qualification is a required GAMP 5 activity for any GxP system. For Florence, the qualification package typically includes review of Florence security and compliance documentation, SOC 2 Type II report, ISO 27001 certificate, business continuity and disaster recovery plans, supplier audit report (vendor or third-party), and a quality and technical agreement that captures responsibilities for validation, change management, incident response, and audit support. We deliver supplier qualification as part of every Florence validation engagement, refreshed on a defined cadence as part of periodic review.
Periodic review is the structured re-confirmation that a validated system still meets its intended use. For Florence, we run periodic review on an annual cadence at minimum (more frequently for high-risk integrations), reviewing: configuration changes since last review, supplier qualification status, validation regression results, change control closures, deviations, audit findings, training compliance, and access reviews. The output is a documented periodic review report with any CAPAs needed to restore validated state. Periodic review pairs naturally with the ongoing managed services retainer because the same team that validated Florence carries the system knowledge forward.
Yes — Florence is specifically designed for inspection readiness. The platform produces inspection-ready binder exports, complete audit trails for any document or action, controlled inspector access (read-only with watermarked viewing), and exportable training and credentialing records. Sponsors, CROs, and sites running Florence have hosted FDA BIMO inspections, EMA GCP inspections, and MHRA inspections with Florence as the system of record. We provide inspection-prep support as a service to help teams rehearse responses, validate completeness, and surface any gaps before the inspector arrives.
Florence is built around the ALCOA+ principles — Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, and Available — defined in the MHRA GxP data integrity guidance and reinforced in FDA data integrity guidance. Every action is attributed to a uniquely identified user; the platform is legible by design; the audit trail captures contemporaneous timestamps; originals are preserved alongside any redacted views; and immutable storage with chain of custody satisfies the "enduring and available" criteria. For migrations from paper or legacy systems, we document the chain of custody and the validation of the migrated state per ALCOA+.
Integration validation follows the same risk-based GAMP 5 pattern. We deliver an interface specification capturing the data contract between Florence and the connected system (Veeva Vault eTMF, Medidata Rave, Oracle Clinical One, CTMS), a risk assessment of the integration's GxP impact, integration test protocols covering happy path, error handling, retry logic, idempotency, and security, and ongoing monitoring of integration health with alerts feeding the change-control process. For event-driven integrations using Florence webhooks, we additionally validate the at-least-once delivery semantics and the deduplication logic on the receiving side. See our integration methodology.
The FDA Computer Software Assurance (CSA) guidance (now finalized for production and quality system software, with a similar paradigm increasingly applied across GxP contexts) emphasizes risk-based, fit-for-purpose assurance rather than exhaustive scripted testing. For Florence this means we focus validation depth on the workflows with the highest patient-safety and data-integrity impact (signatures, audit trail, eHub document flow, monitor access), and use exploratory and unscripted testing on lower-risk configurations. The result is a validation package that is meaningfully smaller, faster to deliver, and easier to maintain than legacy CSV approaches — without compromising compliance.
Once Florence is validated, the work shifts to maintaining validated state through normal operations: change control on configuration changes, integration changes, role and template updates; risk-based regression testing on Florence platform releases; periodic review on the agreed cadence; supplier qualification refresh; access reviews; training compliance; and audit support during FDA, EMA, MHRA, or sponsor inspections. IntuitionLabs offers tiered managed services covering all of these activities so you do not need to staff a dedicated Florence validation team in-house. See our full managed services offering.
Ready to Validate Your Florence Tenant?
Ready to Validate Your Florence Tenant? image

Ready to Validate Your Florence Tenant?

Book a discovery session to scope a risk-based GAMP 5 validation for your Florence deployment — fit-for-purpose, inspection-ready, and aligned to ICH E6(R3).

Book a Meeting

© 2026 IntuitionLabs. All rights reserved.

Privacy PolicyTerms of ServiceBook Meeting